Coya Therapeutics (COYA) Total Current Liabilities (2022 - 2025)
Coya Therapeutics (COYA) has disclosed Total Current Liabilities for 4 consecutive years, with $5.9 million as the latest value for Q4 2025.
- Quarterly Total Current Liabilities rose 53.53% to $5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Dec 2025, up 53.53% year-over-year, with the annual reading at $5.9 million for FY2025, 53.53% up from the prior year.
- Total Current Liabilities hit $5.9 million in Q4 2025 for Coya Therapeutics, up from $3.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $5.9 million in Q4 2025 to a low of $1.2 million in Q2 2023.
- Historically, Total Current Liabilities has averaged $3.5 million across 4 years, with a median of $3.8 million in 2024.
- Biggest YoY gain for Total Current Liabilities was 241.05% in 2024; the steepest drop was 24.3% in 2024.
- Year by year, Total Current Liabilities stood at $3.8 million in 2022, then skyrocketed by 32.13% to $5.1 million in 2023, then decreased by 24.3% to $3.8 million in 2024, then surged by 53.53% to $5.9 million in 2025.
- Business Quant data shows Total Current Liabilities for COYA at $5.9 million in Q4 2025, $3.7 million in Q3 2025, and $4.5 million in Q2 2025.